Hayflick, his limit, and cellular ageing

Nature Reviews Molecular Cell Biology

Volumn 1, Issue 1, 2000, Pages 72-76

  Shay, Jerry W ^a   Wright, Woodring E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

AGING; ART; ARTICLE; CELL AGING; CELL CULTURE; CELL DIVISION; HISTORY; HUMAN; METABOLISM; PHYSIOLOGY; TELOMERE; TIME; UNITED STATES;

AGING; CELL AGING; CELL DIVISION; CELLS, CULTURED; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PORTRAITS; TELOMERASE; TELOMERE; TIME FACTORS; UNITED STATES;

EID: 0034304960     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/35036093     Document Type: Review

References (48)

1. Weismann, A. Collected Essays upon Heredity and Kindred Biological Problems (ed. Poulton, E. B.) (Clarendon, Oxford, 1889).
2. Carrel, A. & Ebeling, A. H. Age and multiplication of fibroblasts. J. Exp. Med. 34, 599-606 (1921).
3. Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621 (1951).
4. Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636 (1965).
5. Witkowski, J. A. Dr. Carrel's immortal cells. Med. Hist. 24, 129-142 (1980).
6. Witkowski, J. A. The myth of cell immortality. Trends Biochem. Sci. 10, 258-260 (1985).
7. Rubin, H. Telomerase and cellular lifespan: ending the debate? Nature Biotechnol. 16, 396-397 (1998).
8. Bumett, M. Intrinsic Mutagenesis (Medical and Technical Publishing Co., Lancaster, 1974).
9. Garfield, E. Current Comments. Curr. Contents 15, 5-8 (1983).
10. Hayflick, L. The coming of age of WI-38. Adv. Cell Cult. 3, 303-316 (1984).
11. Hayflick, L. How and why we age. Exp. Gerontol. 33, 639-653 (1998).
12. Wright, W. E. & Hayflick, L. Nuclear control of cellular ageing demonstrated by hybridization of anucleate and whole cultured normal human fibroblasts. Exp. Cell Res. 96, 113-121 (1975).
13. Watson, J. D. Origin of concatemeric T7 DNA. Nature New Biol. 239, 197-201 (1972).
14. Olovnikov, A. M. Telomeres, telomerase and aging: Origin of the theory. Exp. Gerontol. 31, 443-448 (1996).
15. Olovnikov, A. M. Principles of marginotomy in template synthesis of polynucleotides. Dokl. Akad. Nauk S.S.S.R. 201, 1496-1499 (1971).
16. Olovnikov, A. M. A theory of marginotomy. The incomplete copying of template margin in enzyme synthesis of polynucleotides and biological significance of the problem. J. Theor. Biol. 41, 181-190 (1973).
17. Muller, H. J. in Studies of Genetics: The Selected Papers of H. J. Muller 384-408 (Indiana Univ. Press, Bloomington, 1962).
18. McClintock, B. The stability of broken ends of chromosomes in Zea mays. Genetics 26, 234-282 (1941).
19. Blackbum, E. H. & Gall, J. G. A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J. Mol. Biol. 120, 33-53 (1978).
20. Moyzis, R. K. et al. A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl Acad. Sci. USA 85, 6622-6626 (1988).
21. Cooke, H. J. & Smith, B. A. Variability at the telomeres of human X/Y pseudoautosomal regions. Cold Spring Harb. Symp. Quant. Biol. 51, 213-219 (1986).
22. Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460 (1990).
23. Hastie, N. D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866-868 (1990).
24. DeLange, T. et al. Structure and variability of human chromosome ends. Mol. Cell Biol. 10, 518-527 (1990).
25. Lindsey, J., McGill, N. I., Lindsey, L A., Green, D. K. & Cooke, H. J. In vivo loss of telomere repeats with age in humans. Mutat. Res. 256, 45-48 (1991).
26. Greider, C. W. & Blackbum, E. H. Identification of a specific telomere terminal transferase enzyme with two kinds of primer specificity. Cell 51, 405-413 (1985).
27. Morin, G. B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59, 521-529 (1989).
28. Kim, N.-W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015 (1994).
29. Feng, F. et al. The RNA component of human telomerase. Science 269, 1236-1241 (1995).
30. Nakamura, T. M. et al. Telomerase catalytic subunit homologs from fission yeast and humans. Science 277, 955-959 (1997).
31. Bodnar, A. G. et al. Extension of life span by introduction of telomerase into normal human cells. Science 279, 349-352 (1998).
32. Shay, J. W. & Wright, W. E. The use of telomerized cells for tissue engineering. Nature Biotechnol. 18, 22-23 (2000).
33. Shay, J. W. & Gazdar, A. F. Telomerase in the early detection of cancer. J. Clin. Path. 50, 106-109 (1997).
34. Herbert, B.-S. et al. Inhibition of telomerase leads to eroded telomeres, reduced proliferation, and apoptosis. Proc. Natl Acad. Sci. USA 96, 14276-14281 (1999).
35. Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in ageing skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363-9367 (1995).
36. Shay, J. W. & Wright, W. E. in Ageing Vulnerability: Causes and Interventions (Novartis Foundation Proceedings, in the press).
37. Hayflick, L. A brief overview of the discovery of cell mortality and immortality and of its influence on concepts about ageing and cancer. Pathol. Biol. 47, 1094-1104 (1999).
38. Wright, W. E. & Shay, J. W. Telomere dynamics in cancer progression and prevention: Fundamental differences in human and mouse telomere biology. Nature Med. 6, 849-651 (2000).
39. Hayflick, L. The biology of human aging. Am. J. Med. Sci. 265, 433-445 (1973).
40. Namba, M. et al. in Monograph on Cancer Research Vol. 27, 221-230 (Tokyo Univ. Press, Tokyo, 1981).
41. Shiels, P. G. et al. Analysis of telomere lengths in cloned sheep. Nature 399, 316-317 (1999).
42. Lanza, R. P. et al. Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science 88, 665-669 (2000).
43. Shay, J. W. Telomerase in cancer - diagnostic, prognostic and therapeutic implications. Sci. Am. 4, S26-S34 (1998).
44. Hayflick, L., Plotkin, S. A., Norton, T. W. & Koprowski, H. Preparation of poliovirus vaccines in a human fetal diploid cell strain. Am. J. Hyg. 75, 240-258 (1962).
45. Hayflick, L. Moorhead, P., Pomerat, C. M. & Hsu, T. C. Choice of a cell system for vaccine production. Science 140, 760-763 (1963).
46. Fletcher, M. A., Hessel, L. & Plotkin, S. A. in Developments in Biological Standardization Vol. 93, 97-107 (Basel, Kargert, 1998).
47. Chanock, R. M., Hayflick, L. & Barille, M. F. Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. Proc. Natl Acad. Sci. USA 48, 41-49 (1962).
48. Hayflick, L. Tissue cultures and mycoplasmas. Texas Rep. Biol. Med. 23, 285-303 (1965).